Bison Capital Acquisition Corp.
Status: Deal Closed
U=S+W/2
W=S@11.5
R=S/10
| IPO Proceeds, $M | $60.38M |
|---|---|
| IPO Date | Jun 20, 2017 |
| CEO | James Jiayuan Tong |
| Left Lead | EarlyBirdCapital |
| IPO Cash in Trust | 102.5% |
| SPAC Tenor | 21+[3] |
| IPO Sector |
General
Media/entertainment, consumer services, and healthcare in Asia and North America |
| IPO Geography | Global |
| Target Company | Xynomic |
| Deal Announced | TBD |
| Deal Size, $M | $391.30M |
| Deal Sector | Healthcare |
| Deal Geography | Asia |
| SEC Filings | www.sec.gov |
| Approval Vote | May 14, 2019 |
| Amendment Vote | TBD |
| Closing Date | May 14, 2019 |
Formerly BCAC
XYNO
XYNPW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Bison Capital Acquisition Corp.:
- Structure and cap table
- 7 directors & officers
- 34 filings and events
- 3 underwriters
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Peixin Xu | 45 | President, Director, and Chairman |
| James Jiayuan Tong | 43 | Chief Executive Officer, Director |
| Peng Jin | 41 | Chief Operating Officer and Secretary |
| Charles Vincent Prizzi | 42 | Director |
| Thomas Folinsbee | 49 | Director |
| Fan Bu | 34 | Chief Financial Officer, Principal Accounting Officer |
| Richard Peidong Wu | 53 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| EarlyBirdCapital | BR | 4,400,000 | units |
| Chardan | 500,000 | ||
| I-Bankers Securities | 350,000 | ||
| 5,250,000 | units | ||
| Up-Front UW fee | 3.00 | % | |
| BCMA | 3.00 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.